“We know the time for research investment is now and we are grateful that ovarian cancer remains a priority in Canada. These funds are critical in continuing the momentum and fueling progress. And OCC will use this important funding to transform lives,” says Tania Vrionis, CEO, OCC.
OCC, our network of researchers, clinicians, and our patient community across Canada, applaud the government’s commitment and investment in women’s health.
